— Know what they know.
Not Investment Advice

STSA NASDAQ

Satsuma Pharmaceuticals, Inc.
1W: +4.8% 1M: +1.9% 3M: +24.0% 1Y: -67.7% 3Y: -95.9%
$1.10
Last traded 2023-06-07 — delisted
NASDAQ · Healthcare · Biotechnology · $36.5M mcap · 15M float · 7.96% daily turnover

📊 Key Metrics

TTM
$0M
Revenue
+0.0% YoY
$-63M
Net Income
-12.7% YoY
$-49M
Free Cash Flow
+1.2% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-101.6%
ROA-92.4%
ROIC1449.6%

Valuation

P/E-0.5
P/B-0.2
EV/EBITDA0.3

Leverage

Debt/Equity0.00
Current Ratio7.44
Interest Cov.-321.6x

Quality Scores

Piotroski F2/9
Altman Z-8.69
Beneish M0.00

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms